Levodopa
- Commodity name： Levodopa
- CAS： 59-92-7
Specification: IN-HOUSE,USP
Package: 1kg/5kg/10kg/25kg
Certificate&Documentation: Kosher, Halal, ISO9001
- 产品描述
-
Description
Levodopa can cause developmental toxicity according to state or federal government labeling requirements.
L-dopa is an optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease It has a role as a prodrug, a hapten, a neurotoxin, an antiparkinson drug, a dopaminergic agent, an antidyskinesia agent, an allelochemical, a plant growth retardant, a human metabolite, a mouse metabolite and a plant metabolite. It is a dopa, a L-tyrosine derivative and a non-proteinogenic L-alpha-amino acid. It is a conjugate acid of a L-dopa(1-). It is an enantiomer of a D-dopa. It is a tautomer of a L-dopa zwitterion.
Levodopa is a prodrug of dopamine that is administered to patients with Parkinson's due to its ability to cross the blood-brain barrier. Levodopa can be metabolised to dopamine on either side of the blood-brain barrier and so it is generally administered with a dopa decarboxylase inhibitor like carbidopa to prevent metabolism until after it has crossed the blood-brain barrier. Once past the blood-brain barrier, levodopa is metabolized to dopamine and supplements the low endogenous levels of dopamine to treat symptoms of Parkinson's. The first developed drug product that was approved by the FDA was a levodopa and carbidopa combined product called Sinemet that was approved on May 2, 1975.
Related products
Related products
Specification: IN-HOUSE,USP
Package: 1kg/5kg/10kg/25kg
Certificate&Documentation: Kosher, Halal, ISO9001
Contact Us
Add : No. 317, Kangning Road, Liuyang National Economic & Technical Development Zone, Changsha, Hunan, china
Customer Message
©2025 Copyright © Hunan Bio-essential tech Co., Ltd. Privacy Policy Powered by www.300.cn ChangSha